• LAST PRICE
    4.7300
  • TODAY'S CHANGE (%)
    Trending Up0.1000 (2.1598%)
  • Bid / Lots
    4.5000/ 1
  • Ask / Lots
    5.0000/ 3
  • Open / Previous Close
    4.7100 / 4.6300
  • Day Range
    Low 4.6700
    High 4.8350
  • 52 Week Range
    Low 1.8500
    High 4.9950
  • Volume
    361,062
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 4.63
TimeVolumeCDXS
09:32 ET22424.71
09:33 ET154904.74
09:35 ET7004.69
09:37 ET32174.695
09:39 ET22084.73
09:42 ET46394.74
09:44 ET1004.7477
09:46 ET1004.77
09:50 ET12014.75
09:51 ET9004.75
09:53 ET13004.77
09:55 ET8354.75
09:57 ET7004.745
10:00 ET2004.74
10:04 ET129664.772
10:06 ET28414.76
10:09 ET2004.761
10:11 ET3004.785
10:13 ET3004.781
10:15 ET23194.8
10:20 ET52664.79
10:22 ET8004.79
10:24 ET1004.77
10:26 ET5004.77
10:27 ET3204.771
10:29 ET4004.77
10:31 ET3464.76
10:33 ET18594.775
10:36 ET7004.765
10:38 ET8004.77
10:42 ET18024.775
10:44 ET55004.79
10:45 ET6224.79
10:47 ET26554.8
10:49 ET32004.825
10:51 ET111004.81
10:54 ET8664.8
11:00 ET31004.8
11:02 ET1004.81
11:03 ET10904.82
11:05 ET12744.81
11:07 ET42674.825
11:09 ET4004.821
11:12 ET3004.821
11:14 ET5004.825
11:16 ET8004.821
11:18 ET2004.821
11:20 ET12904.815
11:21 ET3004.82
11:23 ET22744.791
11:25 ET7004.775
11:27 ET20994.77
11:30 ET42394.741
11:32 ET4004.731
11:34 ET4034.73
11:36 ET1004.72
11:38 ET4504.72
11:39 ET5004.72
11:41 ET1004.721
11:43 ET3004.72
11:45 ET5004.721
11:48 ET3004.721
11:50 ET16694.715
11:52 ET8004.72
11:54 ET8604.74
11:57 ET1004.74
12:01 ET6214.73
12:03 ET5634.7246
12:08 ET10004.715
12:10 ET3604.7179
12:12 ET12424.72
12:17 ET2234.73
12:19 ET7744.74
12:26 ET6124.725
12:28 ET84874.77
12:30 ET18544.805
12:32 ET6004.8
12:33 ET5734.805
12:35 ET6474.7921
12:37 ET1004.795
12:46 ET4004.795
12:48 ET6104.795
12:50 ET4034.795
12:51 ET1004.79
12:55 ET1004.79
12:57 ET22004.81
01:00 ET13004.82
01:02 ET4004.825
01:04 ET1004.825
01:06 ET1004.83
01:08 ET4004.835
01:09 ET2004.835
01:13 ET30064.815
01:15 ET4004.795
01:22 ET1004.795
01:24 ET7024.8
01:26 ET2004.81
01:29 ET4034.81
01:36 ET1714.8083
01:38 ET5054.8
01:40 ET3004.8
01:42 ET3004.795
01:45 ET8004.795
01:49 ET1004.8
01:51 ET8584.78
01:54 ET11004.78
01:56 ET3004.77
01:58 ET16004.75
02:03 ET56064.745
02:05 ET20484.75
02:07 ET3004.75
02:09 ET20934.74
02:12 ET35264.72
02:14 ET3504.73
02:16 ET10904.74
02:18 ET2004.74
02:20 ET183974.69
02:21 ET32354.69
02:23 ET2004.685
02:25 ET23034.675
02:27 ET43024.69
02:34 ET13314.685
02:36 ET3134.685
02:39 ET1154.685
02:43 ET2004.685
02:45 ET6774.68
02:48 ET7204.69
02:50 ET16134.6875
02:54 ET1004.69
02:56 ET50984.7
02:57 ET1004.715
02:59 ET2004.72
03:01 ET11744.72
03:03 ET8004.725
03:06 ET2004.73
03:08 ET7844.745
03:10 ET3004.73
03:14 ET51984.7255
03:15 ET2004.73
03:17 ET2004.735
03:19 ET1004.735
03:21 ET13604.73
03:24 ET1004.725
03:26 ET4004.73
03:28 ET4004.735
03:30 ET3004.74
03:32 ET23654.73
03:33 ET1004.725
03:35 ET4334.73
03:39 ET7004.745
03:42 ET2004.75
03:44 ET3104.745
03:46 ET8504.749
03:48 ET20004.75
03:50 ET8164.755
03:51 ET85154.725
03:53 ET9504.73
03:55 ET13104.735
03:57 ET12884.735
04:00 ET422484.73
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCDXS
Codexis Inc
384.9M
-5.4x
---
United StatesADCT
ADC Therapeutics SA
302.6M
-1.3x
---
United StatesPSNL
Personalis Inc
293.2M
-2.5x
---
United StatesFATE
Fate Therapeutics Inc
301.8M
-1.6x
---
United StatesCTNM
Contineum Therapeutics Inc
378.7M
-10.5x
---
United StatesSAGE
SAGE Therapeutics Inc
343.2M
-1.0x
---
As of 2024-12-07

Company Information

Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Contact Information

Headquarters
200 Penobscot DrREDWOOD CITY, CA, United States 94063-4718
Phone
650-421-8100
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Stephen Dilly
Chief Financial Officer
Georgia Erbez
Chief Operating Officer
Kevin Norrett
Senior Vice President - Commercial Operations
Britton Jimenez
Senior Vice President - Intellectual Property
John Schiffhauer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$384.9M
Revenue (TTM)
$64.4M
Shares Outstanding
81.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.16
EPS
$-0.88
Book Value
$1.24
P/E Ratio
-5.4x
Price/Sales (TTM)
6.0
Price/Cash Flow (TTM)
---
Operating Margin
-78.97%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.